Key result
Speed modulation of a continuous-flow total artificial heart successfully generated physiologic arterial pressure waveforms in vitro, requiring 16.2% additional pump power consumption.
Why the study?
Does speed modulation in a continuous-flow total artificial heart simulate a physiologic arterial pressure waveform in an in vitro mock circulatory loop?
Does speed modulation in a continuous-flow total artificial heart simulate a physiologic arterial pressure waveform in an in vitro mock circulatory loop?
Speed modulation in a continuous-flow total artificial heart can successfully simulate physiologic arterial pressure waveforms in vitro, requiring only a modest increase in power consumption.
Answers are grounded in this paper and cite their sources.
Does not yet support clinical adoption of speed modulation in total artificial hearts; leaves open translation to in vivo durability and outcomes.
This study demonstrated the concept of using speed modulation in a continuous-flow total artificial heart (CFTAH) to shape arterial pressure waveforms and to adjust pressure pulsatility. A programmable function generator was used to determine the optimum pulsatile speed profile. Three speed profiles [sinusoidal, rectangular, and optimized (a profile optimized for generation of a physiologic arterial pressure waveform)] were evaluated using the CFTAH mock circulatory loop. Hemodynamic parameters were recorded at average pump speeds of 2,700 rpm and a modulation cycle of 60 beats per minute. The effects of varying physiologically relevant vascular resistance and lumped compliance on the hemodynamics were assessed. The feasibility of using speed modulation to manipulate systemic arterial pressure waveforms, including a physiologic pressure waveform, was demonstrated in vitro. The additional pump power consumption needed to generate a physiologic pulsatile pressure was 16.2% of the power consumption in nonpulsatile continuous-flow mode. The induced pressure waveforms and pulse pressure were shown to be very responsive to changes in both systemic vascular resistance and arterial compliance. This system also allowed pulsatile pulmonary arterial waveform. Speed modulation in the CFTAH could enable physicians to obtain desired pressure waveforms by simple manual adjustment of speed control input waveforms.
No takes yet. Share an insight, caveat, or question.
Shiose et al. (2010) studied Total artificial heart. Speed modulation of continuous-flow total artificial heart (CFTAH) vs. Nonpulsatile continuous-flow mode was evaluated on Hemodynamic parameters and power consumption. Speed modulation of a continuous-flow total artificial heart successfully generated physiologic arterial pressure waveforms in vitro, requiring 16.2% additional pump power consumption.
Synapse has enriched 10 related papers. Consider them for comparative context: